Home
Knowledge Center

Knowledge Center

The latest insights, news, events and webinars from Phastar

The Cutting Edge of Biometrics

Keep up-to-date with the latest trends and developments with insights from our biostatisticians, programmers, and data scientists.

Press Releases

Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards

October 1st, 2025 3 minute read

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as fi...

Press Releases

Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

June 24th, 2025 2 minute read

London, UK, and Durham (NC), US – June 24th, 2025: Phastar, a global specialist biometrics & data science Contrac...

Press Releases

Phastar Secures Finalist Spot at 2025 Citeline Awards

April 10th, 2025 3 minute read

London, UK, and Durham (NC), US – April 10th, 2025: Phastar, a global specialist biometrics & data science Contra...

View all

Events

CMO Summit 360 2026

March 14th, 2026 1 minute read

Phastar is delighted to be exhibiting at the CMO Summit 360, 13-14 April 2026 in Boston MA. Visit the Phastar exhibit...

Events

COG New England 2026

March 10th, 2026 1 minute read

Phastar is delighted to be exhibiting at the COG New England, 28-29 April in Boston MA. Visit the Phastar exhibit at ...

Events

OCT Europe 2026

March 8th, 2026 1 minute read

Phastar is delighted to be exhibiting at the OCT Europe, 6-7 May in Barcelona, Spain. Visit the Phastar exhibit at bo...

View all

Webinars

From Data to Decisions: TMLE, Doubly Robust Methods, and Federated Learning

April 13th, 2026 1 minute read

This webinar will cover methods that are crucial to making informed decisions. Specifically, personalized care throug...

Webinars

Causal Inference in Real World Evidence: What is it? Why now?

January 22nd, 2026 1 minute read

Causal inference is increasingly used to generate real-world evidence (RWE), by regulatory&n...

Webinars

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls

November 20th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...

View all

Case Studies

Efficient Project Management for a Late-Stage Parkinson’s Disease Study

January 6th, 2026 1 minute read

Phastar partnered with a biotechnology sponsor to manage statistical and data management activities for a late-stage ...

Case Studies

Turning Legacy Complexity into Submission-Ready Confidence

November 24th, 2025 1 minute read

Discover how Phastar converted 16 legacy studies into SDTM and delivered a robust Integrated Summary of Safety (ISS) ...

Case Studies

Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies

November 17th, 2025 1 minute read

A sponsor needed to pool data from four MS spasticity studies—one still ongoing with another vendor—while adapting mi...

View all

Articles & Interviews

Key Considerations for Drug Development Pipelines in Early Phase Clinical Trials

April 2nd, 2026 1 minute read

Sam Hinsley, Statistics Manager at Phastar, shares practical insights into early phase clinical trial design in a new...

Articles & Interviews

Shaping the Future of Evidence Generation

March 23rd, 2026 5 minute read

Real-world evidence (RWE) is no longer peripheral to drug development. Across regulatory, HTA and payer env...

Articles & Interviews

The EU’s Health Technology Assessment Regulation: Implementation one year on

March 10th, 2026 1 minute read

Billy Amzal, PhD, Head of Strategic Consulting at Phastar, explores the first year of the EU Health Technology A...

View all

Blogs

Meet the Team: Lisa Gibbons, Principal Statistician

April 10th, 2026 4 minute read

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s succes...

Blogs

Designing Real-World Evidence for Causal Interpretation

March 24th, 2026 4 minute read

Causal inference begins with clarity about the research question. What population, treatment, comparator, and outcome...

Blogs

Building a Purpose-Driven Organization: Leading in Corporate Responsibility

March 23rd, 2026 3 minute read

As we mark B Corp Month 2026, Phastar is reaffirming its commitment to building a purpose-driven organization where p...

View all

Publications

Flexible Dose-Finding in Early-Phase Oncology Combination Studies Enabling Mid-Trial Dose Insertions to Improve Dose Recommendations

April 2nd, 2026 1 minute read

Early-phase oncology combination trials often assume the optimal dose is already included in the dosing gri...

Publications

Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence

December 3rd, 2025 1 minute read

As the pharmaceutical landscape evolves, traditional clinical trial designs are increasingly complemented by innovati...

Publications

Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

April 1st, 2025 1 minute read

Discover how Bayesian statistics can enhance clinical trial efficiency and improve decision-making. Our latest white ...

View all

Knowledge Center

The Cutting Edge of Biometrics

Press Releases

Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards

Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

Phastar Secures Finalist Spot at 2025 Citeline Awards

Events

CMO Summit 360 2026

COG New England 2026

OCT Europe 2026

Webinars

From Data to Decisions: TMLE, Doubly Robust Methods, and Federated Learning

Causal Inference in Real World Evidence: What is it? Why now?

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls

Case Studies

Efficient Project Management for a Late-Stage Parkinson’s Disease Study

Turning Legacy Complexity into Submission-Ready Confidence

Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies

Articles & Interviews

Key Considerations for Drug Development Pipelines in Early Phase Clinical Trials

Shaping the Future of Evidence Generation

The EU’s Health Technology Assessment Regulation: Implementation one year on

Blogs

Meet the Team: Lisa Gibbons, Principal Statistician

Designing Real-World Evidence for Causal Interpretation

Building a Purpose-Driven Organization: Leading in Corporate Responsibility

Publications

Flexible Dose-Finding in Early-Phase Oncology Combination Studies Enabling Mid-Trial Dose Insertions to Improve Dose Recommendations

Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence

Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

Speak to our Team of Experts